De novo galectin-3 expression influences the response of melanoma cells to isatin-Schiff base copper (II) complex-induced oxidative stimulus

Chemico-Biological Interactions

Volumn 206, Issue 1, 2013, Pages 37-46

  Borges, Beatriz E ^a   Teixeira, Verônica R ^b   Appel, Marcia H ^a,c   Steclan, Chelin A ^a   Rigo, Fernanda ^a   Filipak Neto, Francisco ^a   Da Costa Ferreira, Ana M ^b   Chammas, Roger ^b   Zanata, Silvio M ^a   Nakao, Lia S ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c STATE UNIVERSITY OF PONTA GROSSA   (Brazil)

Author keywords

Copper; Galectin 3; Melanoma cells; Metal complex

Indexed keywords

[BIS (2 OXINDOL 3 YL IMINO) 2 (2 AMINOETHYL)PYRIDINE N,N'] COPPER PERCHLORATE; ANTINEOPLASTIC AGENT; COPPER COMPLEX; DICHLORO(2 OXINDOL 3 YL IMINO) 2 (2 AMINOETHYL)PYRIDINE N,N' ZINC COMPLEX; GALECTIN 3; ISATIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ZINC COMPLEX;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CONTROLLED STUDY; MELANOMA CELL; MEMBRANE DEPOLARIZATION; MITOCHONDRION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH;

1-(4,5-DIMETHYLTHIAZOL-2-YL)-3,5-DIPHENYLFORMAZAN; 1-CHLORO-2,4-DINITROBENZENE; 2′,7′,DICHLORODIHYDRO FLUORESCEIN DIACETATE; 4′,6-DIAMIDINO-2-PHENYLINDOLE DIHYDROCHLORIDE; 5,5′-DITHIOBIS (2-NITROBENZOIC ACID); [BIS-(2-OXINDOL-3-YL-IMINO)-2-(2-AMINOETHYL) PYRIDINE-N,N'] COPPER (II) PERCHLORATE; [CU(ISAEPY)(2)](CLO(4))(2); [DICHLORO (2-OXINDOL-3-YL-IMINO)-2-(2-AMINOETHYL) PYRIDINE-N,N′] ZINC (II); [ZN(ISAEPY)CL(2)]; ADENOSINE MONOPHOSPHATE-ACTIVATED PROTEIN KINASE; AMPK; CAT; CATALASE; CDNB; CELLULAR PRION PROTEIN; COPPER; DAPI; DCFH(2)-DA; DTNB; ECM; EXTRACELLULAR MATRIX; GALECTIN-3; GLUTATHIONE-S-TRANSFERASE; GST; HORSERADISH PEROXIDASE; HRP; MELANOMA CELLS; METAL COMPLEX; MTT; PEG; POLYETHYLENE GLYCOL; PRPC; REACTIVE OXYGEN SPECIES; ROS; SOD; SUPEROXIDE DISMUTASE;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; GALECTIN 3; MELANOMA; MICE; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84883691163     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2013.08.005     Document Type: Article

References (59)

1. J. Dumic, S. Dabelic, and M. Flögel Galectin-3: an open-ended story Biochim. Biophys. Acta. 1760 2006 616 635 (Pubitemid 44382499)
2. A.U. Newlaczyl, and L.-G. Yu Galectin-3-a jack-of-all-trades in cancer Cancer Lett. 313 2011 123 128
3. H. Schoeppner, A. Raz, S. Ho, and R.S. Bresalier Expression of an endogenous galactose- binding lectin correlates with neoplastic progression in the colon Carbohydr. Bin Prot. Gastro. Cancer. 75 1995 2818 2826
4. D.K. Hsu, C.A. Dowling, K.C. Jeng, J.T. Chen, R.Y. Yang, and F.T. Liu Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma Int. J. Cancer 81 1999 519 526 (Pubitemid 29203046)
5. S. Saussez, F. Lorfevre, T. Lequeux, G. Laurent, G. Chantrain, F. Vertongen, G. Toubeau, C. Decaestecker, and R. Kiss The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy Oral Oncol. 44 2008 86 93 (Pubitemid 350251284)
6. N. Kapucuoglu, P.Y. Basak, S. Bircan, S. Sert, and V.B. Akkaya Immunohistochemical galectin-3 expression in non-melanoma skin cancers Pathol. Res. Pract. 205 2009 97 103
7. J.S. Knapp, S.D. Lokeshwar, U. Vogel, J. Hennenlotter, C. Schwentner, M.W. Kramer, A. Stenzl, and A.S. Merseburger Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence World J. Urol. 31 2013 351 358
8. V. Castronovo, F.A. Van Den Brûle, P. Jackers, N. Clausse, F.T. Liu, C. Gillet, and M.E. Sobel Decreased expression of galectin-3 is associated with progression of human breast cancer J. Pathol. 179 1996 43 48 (Pubitemid 26182865)
9. V. Castronovo, F.T. Liu, and F.A. Van den Brule Decreased expression of galectin-3 in basal cell carcinoma of the skin Int. J. Oncol. 15 1999 67 70
10. J. Ellerhorst, P. Troncoso, X.C. Xu, J. Lee, and R. Lotan Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer Urol. Res. 27 1999 362 367 (Pubitemid 29526142)
11. E.R. Brown, T. Doig, N. Anderson, T. Brenn, V. Doherty, Y. Xu, J.M.S. Bartlett, J.F. Smyth, and D.W. Melton Association of galectin-3 expression with melanoma progression and prognosis Eur. J. Cancer 48 2012 865 874
12. P. Vereecken, C. Debray, M. Petein, A. Awada, M.-C. Lalmand, M. Laporte, B. Van Den Heule, A. Verhest, R. Pochet, and M. Heenen Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors Arch. Dermatol. Res. 296 2005 353 358 (Pubitemid 40310807)
13. V.G. Prieto, A.A. Mourad-Zeidan, V. Melnikova, M.M. Johnson, A. Lopez, A.H. Diwan, A.J.F. Lazar, S.S. Shen, P.S. Zhang, J.A. Reed, J.E. Gershenwald, A. Raz, and M. Bar-Eli Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma Clin. Cancer Res. 12 2006 6709 6715 (Pubitemid 44876839)
14. L. Larsen, H.-Y. Chen, J. Saegusa, and F.-T. Liu Galectin-3 and the skin J. Dermatol. Sci. 64 2011 85 91
15. S. Kuphal, and A. Bosserhoff Recent progress in understanding the pathology of malignant melanoma J. Pathol. 219 2009 400 409
16. K.E. Lacy, S.N. Karagiannis, and F.O. Nestle Advances in the treatment of melanoma Clin. Med. 12 2012 168 171
17. V.A. Nikolaou, A.J. Stratigos, K.T. Flaherty, and H. Tsao Melanoma: new insights and new therapies J. Invest. Dermatol. 132 2012 854 863
18. F. Spagnolo, and P. Queirolo Upcoming strategies for the treatment of metastatic melanoma Arch. Dermatol. Res. 304 2012 177 184
19. U. Jungwirth, C.R. Kowol, B.K. Keppler, and G. Christian Anticancer activity of metal complexes: involvement of redox processes Antioxid. Redox Signal. 15 2012 1085 1127
20. J.P. Fruehauf, S. Zonis, M. Al-Bassam, A. Kyshtoobayeva, C. Dasgupta, T. Milovanovic, R.J. Parker, and A.C. Buzaid Selective and synergistic activity of L-S, R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase Pigment Cell Res. 10 1997 236 249 (Pubitemid 127524186)
21. H.G.M. Wittgen, and L.C.L.T. Van Kempen Reactive oxygen species in melanoma and its therapeutic implications Melanoma Res. 17 2007 400 409 (Pubitemid 350084996)
22. V. Trapp, K. Lee, F. Doñate, A.P. Mazar, and J.P. Fruehauf Redox-related antimelanoma activity of ATN-224 Melanoma Res. 19 2009 350 360
23. D. Cen, D. Brayton, B. Shahandeh, F.L. Meyskens, and P.J. Farmer Disulfiram facilitates intracellular Cu uptake and induces apoptosis in HUMAN melanoma cells J. Med. Chem. 47 2004 6914 6920 (Pubitemid 40053779)
24. G. Cerchiaro, K. Aquilano, G. Filomeni, G. Rotilio, M.R. Ciriolo, and A.M.D.C. Ferreira Isatin-Schiff base copper(II) complexes and their influence on cellular viability J. Inorg. Biochem. 99 2005 1433 1440 (Pubitemid 40804952)
25. M.E. Lane, B. Yu, A. Rice, K.E. Lipson, C. Liang, L. Sun, C. Tang, G. Mcmahon, R.G. Pestell, and S. Wadler A Novel cdk2-selective Inhibitor, SU9516, induces apoptosis in colon Carcinima cells Cancer Res. 61 2001 6170 6177 (Pubitemid 32762555)
26. V.C. da Silveira, J.S. Luz, C.C. Oliveira, I. Graziani, M.R. Ciriolo, and A.M. da Costa Ferreira Double-strand DNA cleavage induced by oxindole-Schiff base copper(II) complexes with potential antitumor activity J. Inorg. Biochem. 102 2008 1090 1103
27. G. Filomeni, G. Cerchiaro, A. Maria, D. Costa, A. De Martino, J.Z. Pedersen, G. Rotilio, M.R. Ciriolo, A.M. Da Costa Ferreira, and A. De Martino Pro-apoptotic activity of novel Isatin-Schiff base copper (II) complexes depends on oxidative stress induction and organelle-selective damage J. Biol. Chem. 282 2007 12010 12021 (Pubitemid 47100713)
28. G. Filomeni, S. Piccirillo, I. Graziani, S. Cardaci, A.M. Da Costa Ferreira, G. Rotilio, and M.R. Ciriolo The isatin-Schiff base copper(II) complex Cu(isaepy)2 acts as delocalized lipophilic cation, yields widespread mitochondrial oxidative damage and induces AMP-activated protein kinase-dependent apoptosis Carcinogenesis 30 2009 1115 1124
29. G. Filomeni, S. Cardaci, A.M. Da Costa Ferreira, G. Rotilio, and M.R. Ciriolo Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: evidence for a combined use with 3-bromopyruvate in neuroblastoma treatment Biochem. J. 437 2011 443 453
30. S. Oba-Shinjo, and M. Correa Melanocyte transformation associated with substrate adhesion impediment Neoplasia 8 2006 231 241 (Pubitemid 43671239)
31. G.A. de Souza, L.M.F. Godoy, V.R. Teixeira, A.H. Otake, A. Sabino, J.C. Rosa, A.R. Dinarte, D.G. Pinheiro, W.A. Silva, M.N. Eberlin, R. Chammas, and L.J. Greene Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation Proteomics 6 2006 1460 1470
32. J.-M. Li, and A.M. Shah Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells J. Biol. Chem. 277 2002 19952 19960 (Pubitemid 34967517)
33. K. Naliwaiko, A.C. Luvizon, L. Donatti, R. Chammas, A.F. Mercadante, S.M. Zanata, and L.S. Nakao Guanosine promotes B16F10 melanoma cell differentiation through PKC-ERK 1/2 pathway Chem. Biol. Interact. 173 2008 122 128
34. M. Paulsson, M. Aumailley, R. Deutzmann, R. Timpl, K. Beck, and J. Engel Laminin-nidogen complex. Extraction with chelating agents and structural characterization Eur. J. Biochem. 166 1987 11 19
35. T. Yatohgo, M. Izumi, H. Kashiwagi, and M. Hayashi Novel purification of vitronectin from human plasma by heparin affinity chromatography Cell Struct. Funct. 13 1988 281 292
36. E. Engvall, and E. Ruoslahti Binding of soluble form of fibroblast surface protein, fibronectin, to collagen Int. J. Cancer 20 1977 1 5 (Pubitemid 8139735)
37. N. Taniguchi, and J. Gutteridge Experimental Protocols for Reactive Oxygen and Nitrogen Species first ed. 2000 Oxford University Press New York
38. H. Keen, B. Jakoby, J.H. Keen, W.H. Habig, and W.B. Jakoby Mechanism for the several activities of the glutathione S-transferases J. Biol. Chem. 251 1976 6183 6188
39. R.K. Crouch, S.E. Gandy, G. Kimsey, R.A. Galbraith, G.M. Galbraith, and M.G. Buse The inhibition of islet superoxide dismutase by diabetogenic drugs Diabetes 30 1981 235 241 (Pubitemid 11026320)
40. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
41. M.A. Baker, G.J. Cerniglia, and A. Zaman Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples Anal. Biochem. 190 1990 360 365 (Pubitemid 20371981)
42. P. Sharma, S.A.V. Raghavan, R. Saini, and M. Dikshit Ascorbate-mediated enhancement of reactive oxygen species generation from polymorphonuclear leukocytes: modulatory effect of nitric oxide J. Leukoc. Biol. 75 2004 1070 1078 (Pubitemid 38720649)
43. G. Manfredi, L. Yang, C.D. Gajewski, and M. Mattiazzi Measurements of ATP in mammalian cells Methods 26 2002 317 326 (Pubitemid 34971571)
44. R. Yang, D.K. Hsu, and F. Liu Expression of galectin-3 modulates T-cell growth and apoptosis Proc. Natl. Acad. Sci. 93 1996 6737 6742 (Pubitemid 26230379)
45. H.C. Kim, H. Lin, H. Biliran, and A. Raz Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells Cancer Res. 59 1999 4148 4154 (Pubitemid 29393591)
46. S. Akahani, P. Nangia-Makker, H. Inohara, H.C. Kim, and A. Raz Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family Cancer Res. 1 1997 5272 5276 (Pubitemid 27516362)
47. P. Matarrese, N. Tinari, M.L. Semeraro, C. Natoli, S. Iacobelli, and W. Malorni Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis FEBS Lett. 473 2000 311 315 (Pubitemid 30249145)
48. T. Fukumori, Y. Takenaka, T. Yoshii, H.C. Kim, V. Hogan, H. Inohara, S. Kagawa, and A. Raz CD29 and CD7 mediate galectin-3-induced Type II T-Cell apoptosis Cancer Res. 63 2003 8302 8311 (Pubitemid 37549482)
49. Y. Suzuki, T. Inoue, T. Yoshimaru, and C. Ra Galectin-3 but not galectin-1 induces mast cell death by oxidative stress and mitochondrial permeability transition Biochim. Biophys. Acta 1783 2008 924 934
50. A.P. Fernandes Bertocchi, G. Campanhole, P.H.M. Wang, G.M. Gonçalves, M.J. Damião, M.A. Cenedeze, F.C. Beraldo, V. de Paula Antunes Teixeira, M.A. Dos Reis, M. Mazzali, A. Pacheco-Silva, and N.O.S. Câmara A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury Transplant. Int. 21 2008 999 1007
51. C.M.O.S. Alves, D.A.O. Silva, A.E.C.S. Azzolini, C.M. Marzocchi-Machado, Y.M. Lucisano-Valim, M.C. Roque-Barreira, and J.R. Mineo Galectin-3 is essential for reactive oxygen species production by peritoneal neutrophils from mice infected with a virulent strain of Toxoplasma gondii Parasitology 140 2013 210 219
52. E. Shinars, T. Navokg, and M. Cheviongll The analogous mechanisms of enzymatic inactivation induced by ascorbate and superoxide in the presence of copper J. Biol. Chem. 258 1983 14778 14783
53. D.-W. Kim, K.H. Kim, B.C. Yoo, S.-H. Hong, Y.C. Lim, Y.-K. Shin, and J.-G. Park Identification of mitochondrial F(1)F(0)-ATP synthase interacting with galectin-3 in colon cancer cells Cancer Sci. 99 2008 1884 1891
54. S. Yamaki, T. Fujii, R. Yajima, T. Hirakata, S. Yamaguchi, T. Fujisawa, S. Tsutsumi, T. Asao, Y. Yanagita, M. Iijima, and H. Kuwano Clinicopathological significance of decreased galectin-3 expression and the long-term prognosis in patients with breast cancer Surg. Today 43 2012 901 905
55. F.-T. Liu, and G. Rabinovich Galectins as modulators of tumour progression Nat. Rev. 5 2005 29 41 (Pubitemid 40052323)
56. Y. Wang, V. Balan, D. Kho, V. Hogan, P. Nangia-Makker, and A. Raz Galectin-3 regulates p21 stability in human prostate cancer cells Oncogene 2012 10.1038/onc.2012.528
57. D.A. Scott, A.D. Richardson, F.V. Filipp, C.A. Knutzen, G.G. Chiang, Z.A. Ronai, A.L. Osterman, and J.W. Smith Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect J. Biol. Chem. 286 2011 42626 42634
58. J. Chun, E.J. Joo, M. Kang, and Y.S. Kim Platycodin D induces anoikis and caspase-mediated apoptosis via p38 MAPK in AGS human gastric cancer cells J. Cell. Biochem. 114 2013 456 470
59. H.J. Woo, M.M. Lotz, J.U. Jung, and A.M. Mercurio Carbohydrate-binding protein 35 (Mac-2), a laminin-binding lectin, forms functional dimers using cysteine 186 J. Biol. Chem. 266 1991 18419 18422 (Pubitemid 21908097)